Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) [clinicaltrials:NCT02375685]
Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) [clinicaltrials:NCT02375685]
Bio2RDF identifier
NCT02375685
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT02375685
identifiers.org URI
acronym [clinicaltrials_vocabulary:acronym]
EYEGUARD-X
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The objective of this s ...... m treatment with gevokizumab.
brief title [clinicaltrials_vocabulary:brief-title]
Long-term Safety of Gevokizuma ...... nfectious Uveitis (EYEGUARD-X)
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2020-05-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2015-02-16T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Behçet's disease uveitis
Intermediate Uveitis
Non-infectious Uveitis
Posterior Uveitis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-03-02T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
nct id [clinicaltrials_vocabulary:nct-id]
NCT02375685
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
A Safety Open-label Study of G ...... on Study. The EYEGUARD-X Study
org study id [clinicaltrials_vocabulary:org-study-id]
CL3-78989-019
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2020-04-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
2013-004973-29
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2014-08-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-03-01T00:00:00Z
identifier
clinicaltrials:NCT02375685
title
Long-term Safety of Gevokizuma ...... nfectious Uveitis (EYEGUARD-X)
@en
type
label
Long-term Safety of Gevokizuma ...... ) [clinicaltrials:NCT02375685]
@en